Impact of Rifabutin on the Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor

NCT04840862 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Drug Drug Interaction

Interventions

DRUG: Trikafta [orange tablet containing ELX 100mg, TEZ 50mg, and IVA 75mg]
DRUG: Rifabutin 300mg

Sponsor

University of Southern California